First U.S. Clinical Laparoscopic Procedure with
New Percuvance® System Performed at the Duke Center for Metabolic
and Weight Loss Surgery
Teleflex Launches Ambitious Efforts to
Accelerate Growing Acceptance Worldwide of Percutaneous Laparoscopy
Now Performed in 14 Countries
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical technologies for critical care and surgery, has announced
today that it has officially launched its second-generation
Percuvance® Percutaneous Surgical System and that the first
clinical laparoscopic procedures in the U.S. using the system were
performed at the Duke Center for Metabolic and Weight Loss Surgery.
Teleflex’s latest advance in percutaneous laparoscopy is more
versatile and enables procedures to be even less invasive than its
first-generation system while delivering the performance of 5 mm
laparoscopic devices commonly used in minimally invasive surgeries
(MIS) with less trauma.
The initial sleeve gastrectomy, Roux-en-Y gastric bypass, and
laparoscopic gastric band removal procedures were performed by Dr.
Dana D. Portenier* and his team. Dr. Portenier is the Chief of
General Surgery at Duke Regional Hospital and the Division Chief at
the Duke Center for Metabolic and Weight Loss Surgery.
“These are increasingly common but often challenging
procedures,” said Dr. Portenier. “Our experiences with the new
system are consistent with other clinical studies, which showed
that its handling and functionality were similar to standard 5-mm
laparoscopic instrumentation. Further research will determine
whether the system’s smaller incisions could potentially
demonstrate improvements in patient pain, cosmesis, and
satisfaction.”
The second-generation, 2.9 mm Percuvance System features
additional interchangeable 5mm tool tips and a new quick-connect
system to facilitate fast and secure tool-tip changes outside of
the body. The system has the performance and versatility for use in
common and advanced general laparoscopic procedures, including
laparoscopic cholecystectomy, upper gastrointestinal, gastric,
bariatric, colorectal and hernia. It enables surgeons to eliminate
one or more additional trocars from their laparoscopic procedures
versus the first-generation device while delivering the outcomes
and performance they expect from their traditional laparoscopic
devices.
The first generation Percuvance System has been used by more
than 150 surgeons in the U.S. and EMEA since Teleflex implemented a
limited release of the first-generation system in March 2015. The
second-generation Percuvance device recently received FDA clearance
and CE Mark approval. During the next month, a series of surgical
procedures with the new Percuvance System will be conducted at
other leading institutions in New York, Texas, Florida and
California by surgeons with experience using the first-generation
system.
“Our second-generation Percuvance System represents a
significant advancement in the ongoing and perpetual evolution of
minimally invasive surgery and is demonstrative of Teleflex’s
unwavering commitment to innovation,” said John Tushar, President
and General Manager of Teleflex Surgical. “We are encouraged by
surgeons’ enthusiastic response to our percutaneous surgical
devices and are optimistic the new Percuvance System will become a
new standard of care in laparoscopic surgery.”
Teleflex is ramping up its sales and marketing efforts to
familiarize surgeons worldwide with the unique performance
capabilities and benefits of the 2.9 mm Percuvance System.
Percutaneous Laparoscopy: The next stage in the evolution of
MIS
Traditional laparoscopic surgery revolutionized surgical
practices more than 30 years ago, and approximately 3 million
laparoscopic procedures are performed each year in the US1. Since
the early 2000s, new technologies and devices have been introduced
with the goal of making these surgeries increasingly less invasive.
None, however, has yet to become widely accepted in general
practice for common laparoscopic procedures.
Percutaneous laparoscopy is a new category of laparoscopic
surgery promoted by Teleflex to overcome the barriers that slowed
widespread acceptance of other approaches. In developing the new
Percuvance System, Teleflex listened to surgeons who said they
wanted:
- Even less invasive surgical practices
that do not compromise performance
- Reduced trauma and scarring
- A device that didn’t require them to
learn a new, complicated surgical technique.
“No matter what the surgery, patients generally prefer and are
more satisfied with smaller incisions,” said Dr. Chan W. Park†,
Assistant Professor of Surgery at Duke University School of
Medicine and a surgeon at the Duke Center for Metabolic and Weight
Loss Surgery. “The development of new options for less invasive
surgery that may also minimize discomfort for patients always
represents a step forward in clinical care.”
The Percuvance System has a short learning curve and requires
few adjustments to surgeons’ current techniques. In addition, it
does not have the high costs associated with capital, service and
fully disposable technologies.
About the Percuvance® System
Teleflex’s Percuvance® Percutaneous Surgical System is a family
of instruments used to perform laparoscopic procedures. It includes
components that introduce a variety of instrument configurations
into the abdominal cavity and requires a smaller incision site than
traditional laparoscopic surgery. It offers reusable handles and
seven disposable 5 mm interchangeable tool tips, which include
graspers, scissors, dissector, electrocautery tools, and a Weck®
Hem-o-lok® Polymer Ligation Clip Applier. Unlike some other
laparoscopic devices, the Percuvance® System affords a percutaneous
insertion into the patient without the use of an insertion trocar.
The Percuvance® Percutaneous Surgical System with 5 mm attachments
is indicated for the means to penetrate soft tissue to access
certain areas of the abdomen. The systems are used to grasp,
manipulate, cut, cauterize, and deliver Hem-o-lok System ligating
clips to soft tissue during laparoscopic surgery.
Click here for animated video Teleflex.com/Percuvance
Teleflex Portfolio of Percutaneous Solutions
The Percuvance System complements another key product, the
MiniLap® Percutaneous Surgical System, in Teleflex’s growing
portfolio of innovative yet practical solutions for percutaneous
laparoscopy. The MiniLap System provides delivery and function
through fully integrated and disposable 2.3 and 2.4 mm devices.
Like the Percuvance System, the MiniLap System does not require a
trocar for initial access and makes minimally invasive procedures
even less invasive for procedures where common retraction,
manipulation, and monopolar energy are required.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed
to improve the health and quality of people’s lives. We apply
purpose driven innovation – a relentless pursuit of identifying
unmet clinical needs – to benefit patients and healthcare
providers. Our portfolio is diverse, with solutions in the fields
of vascular and interventional access, surgical, anesthesia,
cardiac care, urology, emergency medicine and respiratory care.
Teleflex employees worldwide are united in the understanding that
what we do every day makes a difference. For more information,
please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®,
Pilling®, Rusch® and Weck® – trusted brands united by a common
sense of purpose.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management's current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
Teleflex, the Teleflex logo, Arrow, Deknatel, Hudson RCI, LMA,
MiniLap, Percuvance, Rüsch, Weck, and Hem-o-Lok are trademarks or
registered trademarks of Teleflex Incorporated or its affiliates,
in the U.S. and/or other countries. © 2016 Teleflex Incorporated.
All rights reserved. MC-002526
References:
1 Source: Millennium Research Group, Inc, RPUS30LA13 | November
2014, US MARKETS FOR LAPAROSCOPIC DEVICES 2015, p30, figure 4.
*Dr. Dana Portenier is a paid consultant of Teleflex.†Dr. Chan
Park is a paid consultant of Teleflex.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160815005047/en/
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President,
Investor Relations610-948-2836orMedia Contact:Sam Brown
Inc.Mike Beyer, 312-961-2502mikebeyer@sambrown.com
Teleflex (NYSE:TFX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2023 to Apr 2024